BMO initiates Pfizer at outperform, says Covid drugs and strong pipeline will boost pharma stock

A person walks past the Pfizer Headquarters building in New York, December 7, 2020.
Carlo Allegri | Reuters

The trend of strong drug development and stock outperformance should continue for Pfizer, making it a smart bet for investors, according to BMO Capital Markets.

More In Street Calls

CNBC ProHere are Friday's biggest analyst calls of the day: Amazon, Marvell, Honeywell, FedEx, Chipotle & more
CNBC ProDeutsche Bank initiates Peloton at buy, says the stock can rebound more than 70%
CNBC ProWall Street analysts bail on DocuSign after sales guidance comes up short